At Community Care of North Carolina, there is not only a focus on global performance metrics, but also the programs and metrics that will contribute to improving those global outcomes metrics, explained Troy Trygstad, PharmD, MBA, PhD, vice president of pharmacy programs at Community Care of North Carolina.
PharmD, MBA, PhD, vice president of pharmacy programs at Community Care of North Carolina.
At Community Care of North Carolina, there is not only a focus on global performance metrics, but also the programs and metrics that will contribute to improving those global outcomes metrics, explained Troy Trygstad,
Transcript (slightly modified for readability)
How does Community Care of North Carolina determine on which quality metrics to focus?
For me one of the privileges of working with Community Care for 13-plus years is that there has been a focus on performance metrics that are more global with the overarching goal of "how do you reduce the cost of care through better health and ebtter health trajectories?" So what's fun and interesting and I think works really well is you have multiple providers who have shared metrics at a global level—so that might be a hospitalization rate, that might be emergency department (ED) rate, it might be what's the total cost of care for patients over a period of time—but at the same time the various actors that are involved in working together to get to that global outcome have metrics that can help them understand better how they're contributing to that global outcome.
For pharmacy, it's the privilege of having global outcomes be part of your performance. It's a privilege and it's something we should aspire to. We want to be able to be responsible on some level for hospitalization rates, ED rates, and global outcomes. But at the same time we want to make sure that from a pharmacy program perspective that those intermediate outcomes are outcomes that are of quality that lead to, we think, better global outcomes like adherence, comprehensive medication review quality and completion, responsiveness to referrals for curb-side consults for medication information, a compliance and persistency program, opioid overuse, and high-risk medications.
All of those types of performance measures are in support of the global measures. I would say that that is the privilege of working with Community Care of North Carolina as pharmacy director, is access to and responsibility for the global metrics, but also focusing on the areas of medication optimization programs and those metrics that indicate a high level of performance with medication optimization that we believe lead to those global outcome metrics.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More